• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


52.1200 USD 0.4400 0.85%

As of 20:10:00 ET on 08/19/2014.

Snapshot for Incyte Corp (INCY)

Open: 51.9500 Day's Range: 51.4601 - 52.4100 Volume: 554,221
Previous Close: 51.6800 52wk Range: 26.5100 - 70.8600 1-Yr Rtn: +93.04%

Stock Chart for INCY

No chart data available.
  • INCY:US 52.0700
  • 1D
  • 1M
  • 1Y
Interactive INCY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INCY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7567
Est. EPS (USD) (12/2014) -0.1970
Est. PEG Ratio -
Market Cap (M USD) 8,777.63
Shares Outstanding (M) 168.41
30 Day Average Volume 984,222
Price/Book (mrq) -
Price/Sale (ttm) 22.8142
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INCY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INCY

Incyte Corporation is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. The Company has drug discovery programs underway focused on the identification of new small molecule drugs for cancer and inflammation.

Herve HoppenotPresident/CEODavid C HastingsExec VP/CFO
James M Daly "Jim"Exec VP/Chief Commercial OfcrRichard S LevyExec VP/Chief Drug Dev & Medical Ofcr
More Company Profile & Key Executives for INCY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil